# Anixa Biosciences Inc: Form 8-K, filed Oct 28, 2021

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: 8-K
- Filed: 2021-10-28
- Accepted by EDGAR: Oct 28, 2021, 16:54 ET
- Period: 2021-10-26
- Accession: 0001493152-21-026636
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315221026636/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315221026636/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315221026636/form8-k.htm

Filed Oct 28, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-026636. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.
